Published June 1, 2023
| Version v1
Dataset
Open
Serum miRnome Profiling: A Novel Biomarker Platform for the Early Detection of NSCLC
Authors/Creators
- 1. Center of Experimental Medicine, Medical University of Bialystok, 15-369 Bialystok, Poland
- 2. Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland
- 3. 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland
- 4. Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok, Po-land
- 5. 1st Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland
- 6. Szentagothai Research Center, Genomic and Bioinformatic Core Facility, H-7624 Pecs, Hungary
- 7. Turku Bioscience Centre, University of Turku & Åbo Akademi University
- 8. Department of Thoracic Surgery, Medical University of Bialystok, 15-276 Bialystok, Poland
- 9. Department of Oncology, Medical University of Warsaw, 02-091 Warsaw, Poland
- 10. Biobank, Medical University of Bialystok, 15-269 Bialystok, Poland
- 11. Department of Hematology Diagnostics and Genetics, The University Hospital, 30-688 Krakow
- 12. Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok
Description
Table S1: DEmiRNAs between cancerous and non-cancerous patients; Table S2: Shared DE miRNAs between subgroups; Table S3: NSCLC vs control_GO_BP_results; Table S4: NSCLC vs control_GO_CC_results; Table S5: NSCLC vs control_GO_MF_results; Table S6: NSCLC vs control_KEGG_results.